Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human B lymphoma cell surface triggers Cbl tyrosine phosphorylation, its association with p85 subunit, Crk-L and Syk and its dissociation with Vav

Cellular Signalling

Volumn 18, Issue 8, 2006, Pages 1219-1225

  Lottin Divoux, Séverine ^a   Jean, Didier ^a   Le Romancer, Murielle ^a   Frade, Raymond ^a  

^a Parc Scientifique de Luminy   (France)

Author keywords

CR2; Epstein Barr virus C3d receptor; Human B lymphoma; Signal transduction

Indexed keywords

BCR ABL PROTEIN; CBL PROTEIN; CD19 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; CRK LIKE PROTEIN; GLYCOPROTEIN GP 140; ONCOPROTEIN; PROTEIN KINASE SYK; PROTEIN P120; PROTEIN P85; PROTEIN SH2; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; PROTOONCOPROTEIN; TYROSINE; UNCLASSIFIED DRUG; VAV PROTEIN; NUCLEAR PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTYROSINE; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; DISSOCIATION; ENZYME ACTIVITY; ENZYME INHIBITION; EPSTEIN BARR VIRUS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INCUBATION TIME; LYMPHOMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION; BIOLOGICAL MODEL; DRUG EFFECT; IMMUNOLOGY; LYMPHOMA; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SRC HOMOLOGY DOMAIN; VIROLOGY; VIRUS ACTIVATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; HERPESVIRUS 4, HUMAN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOMA; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN BINDING; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-CBL; PROTO-ONCOGENE PROTEINS C-VAV; RECEPTORS, COMPLEMENT 3D; SRC HOMOLOGY DOMAINS; VIRUS ACTIVATION;

EID: 33746282496     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellsig.2005.10.001     Document Type: Article

References (31)

1. Barel M., Charriaut C., and Frade R. FEBS Lett. 136 (1981) 111
2. Frade R., Myones B.L., Barel M., Krikorian L., Charriaut C., and Ross G.R. Eur. J. Immunol. 15 (1985) 1192
3. Fingeroth J.D., Weis J.J., Tedder T.F., Strominger J.L., Biro P.A., and Fearon D.T. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 4510
4. Frade R., Barel M., Ehlin-Henriksson B., and Klein G. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 1490
5. Tanner J., Weis J., Fearon D.T., Whang Y., and Kieff E. Cell 50 (1987) 203
6. Barel M., Fiandino A., Delcayre A.X., Lyamani F., and Frade R. J. Immunol. 141 (1988) 1590
7. Moore M.D., Cooper N.R., Tack B.F., and Nemerow G.R. Proc. Natl. Acad. Sci. U. S. A. 8 (1987) 9194
8. Weis J.J., Toothaker L.E., Smith J.A., Weis J.H., and Fearon D.T. J. Exp. Med. 167 (1988) 1047
9. Barel M., Balbo M., and Frade R. Mol. Immunol. 35 (1998) 1025
10. Hatzfeld J., Charriaut-Marlangue C., Levesque J.P., Barel M., Stancou R., Krikorian L., Hatzfeld A., and Frade R. Ann. Inst. Pasteur., Immunol. 138 (1987) 451
11. Frade R., Crevon M.C., Barel M., Vasquez A., Krikorian L., Charriaut C., and Galanaud P. Eur. J. Immunol. 15 (1985) 73
12. Nemerow G.R., McNaughton M.E., and Cooper N.R. J. Immunol. 135 (1985) 3068
13. Melchers F., Erdei A., Schultz T., and Dierich M.P. Nature 317 (1985) 264
14. Masucci M.G., Szigeti R., Ernberg L., Hu C.P., Torsteinsdottir S., Frade R., and Klein E. Eur. J. Immunol. 17 (1987) 815
15. Carter R.H., Spycher M.O., Ng Y.C., Hoffman R., and Fearon D.T. J. Immunol. 141 (1988) 457
16. Bradbury L.E., Kansas G.S., Levy S., Evans R.L., and Tedder T.F. J. Immunol. 149 (1992) 2841
17. Barel M., Vasquez A., Charriaut C., Aufredou M.T., Galanaud P., and Frade R. FEBS Lett. 197 (1986) 353
18. Carel J.C., Myones B.L., Frazier B., and Holers V.M. J. Biol. Chem. 265 (1990) 12293
19. Balbo M., Barel M., Bouillie S., Drané P., Cassinat B., and Frade R. Mol. Immunol. 32 (1995) 1295
20. Bouillie S., Barel M., and Frade R. J. Immunol. 162 (1999) 136
21. Barel M., Le Romancer M., and Frade R. J. Immunol. 166 (2001) 3167
22. Barel M., Balbo M., Le Romancer M., and Frade R. Eur. J. Immunol. 33 (2003) 2557
23. Tsygankov A.Y., Teckchandani A.M., Feshchenko E.A., and Swaminathan G. Oncogene 20 (2001) 6382
24. Lupher Jr. M.L., Rao N., Eck M.J., and Brand H. Immunol. Today 20 (1999) 375
25. Thien C.B.F., and Langdon W.Y. Nat. Rev., Mol. Cell Biol. 2 (2001) 294
26. Duan L., Reddi A.L., Ghosh A., Dimri M., and Band H. Immunity 21 (2004) 7
27. Ota Y., Beitz L.O., Scharenberg A.M., Donovan J.A., Kinet J.P., and Samelson L.E. J. Exp. Med. 184 (1996) 1713
28. Deckert M., Elly C., Altman A., and Liu Y.C. J. Biol. Chem. 273 (1998) 8867
29. Bustelo R.X. Oncogene 20 (2001) 6372
30. Matsumoto A.K., Kopicky-Burd A., Carter J.R.H., Tuveson D.A., Tedder T.F., and Fearon D.T. J. Exp. Med. 173 (1991) 55
31. Sattler M., Pride Y.B., Quinnan L.R., Verma S., Malouf N.A., Husson H., Salgia R., Lipkowitz S., and Griffin J.D. Oncogene 21 (2002) 1423